NEW YORK, Oct. 30 – Motorola announced Monday it has completed development of its eSensor low-density clinical microarray, and will begin manufacturing this instrument in the second quarter of next year.
The company’s Clinical Micro Sensors business unit is making the sensors to do DNA testing for health care, agriculture, and environmental monitoring, as previously reported in GenomeWeb.
Motorola’s own studies have found the chips to be effective in detecting SNPs, panels of bacterial or viral targets, and genetically modified crops, the company said.
The sensors, which have small numbers of probes, run on the principle of bioelectronics, which uses organic molecules to form electronic circuits that detect numerous DNA and RNA targets at once.
Motorola expects to manufacture and ship the first eSensor instruments to researchers in agricultural diagnostics.